Cardiovascular

Comprehensive Cardiovascular Clinical Research

Clinicalae has extensive experience in cardiovascular clinical research trials, spanning the entire drug development spectrum. Despite significant advances in the cardio-metabolic field over the past two decades, cardiovascular and metabolic diseases continue to be the leading causes of morbidity and mortality worldwide. There remains a critical need for the discovery and development of better, safer, and more cost-effective drugs and devices.

Data-Driven Approach

As a full-service provider, Clinicalae employs a data-driven approach to develop strategies that reduce timelines and costs from First-in-Human (FIH) studies through post-approval stages. With over 25 years of experience in conducting cardiovascular trials, we emphasize key cardiovascular and metabolic indications such as heart failure, lipid disorders, diabetes, renal insufficiency and transplant, arrhythmia, and rare diseases.

Expertise Across Multiple Indications

Our experienced cardio-metabolic drug and medical device development teams support clinical trials across a broad range of cardiovascular and metabolic indications, including:

Cardiovascular

Atrial and Ventricular Arrhythmia
Cardiomyopathy: Including ATTR and hypertrophic cardiomyopathy, supported by our rare disease team.
Heart Failure
Hypertension
Pulmonary Hypertension: Collaboration with our respiratory team.
Coronary Artery Disease and Stable Angina
Acute Coronary Syndromes: Including myocardial infarction.
Venous Thromboembolism
Peripheral Arterial Disease

Atherosclerotic & Embolic Cerebrovascular Disease

Stroke and Transient Ischemic Attack (TIA): Supported by our neurosciences team.

Metabolic

Diabetes
Dyslipidemia
Hyperuricemia

Why Choose Clinicalae for Your Cardiovascular Trials?

Extensive Experience: Over 25 years in cardiovascular clinical trials, with a focus on both common and rare diseases.
Data-Driven Strategies: Leveraging data to streamline processes, reduce costs, and shorten timelines.

Comprehensive Support: From FIH studies to post-approval stages, ensuring robust and reliable trial outcomes.
Global Reach: A vast network of over 3,929 sites worldwide, ensuring broad patient access and diverse data collection.

Interdisciplinary Expertise: Collaboration across specialized teams in rare diseases, neurosciences, and respiratory medicine to provide comprehensive trial support.

Join Us in Transforming Healthcare

We invite you to be a part of the healthcare revolution. Collaborate with us to drive innovation, improve patient outcomes, and shape the future of healthcare. Together, let’s make a difference in the lives of millions.